Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
11/12/2014 Strategy for Vhl conditional knockout: Conditional inactivation of the von Hippel–Lindau tumor suppressor gene: Mouse model Two independent Hoxb7-Cre lines: Expressed early in collecting ducts and distal tubules; not in proximal tubules. Hoxb7-Cre x VhlloxP/loxP: 18 mutant (Hoxb7-Cre; VhlloxP/loxP); 13 wild-type (Hoxb7-Cre or VhlloxP/loxP) Hoxb7-Cre-EGFP x VhlloxP/loxP: 17 mutant (Hoxb7-Cre-EGFP; VhlloxP/loxP); 10 wild-type (Hoxb7-Cre-EGFP or VhlloxP/loxP) Tien Hsu Boston University School of Medicine National Central University, Taiwan Oncogene. 2014 Jul 14;0. [Epub ahead of print] 2014 VHL Symposium, Madrid Conditional Vhl knockout in kidney tubule cells (Hoxb7-Cre) Appearance of clear cells with abnormal nuclei and basement membrane breakdown w.t. Periodic acidSchiff's stain Vhlhdel/del w.t. A 200X B Vhlhdel/del C Vhlhdel/del D * Vhlhdel/del E * 100 m * * 100 m H & E stain Vhlhdel/del Vhlhdel/del * Gl f Dilated tubules (minicysts) Infiltration of interstitial cells Increased density of vasculature Appearance of transformed clear cells Oncogene. 2014 Jul 14;0. [Epub ahead of print] * * Vhlhdel/del Abnormal clear cells Basement membrane breakdown Proteinaceous cast in dilated tubules Oncogene. 2014 Jul 14;0. [Epub ahead of print] 1 11/12/2014 A majority of abnormal tubules resides in the ascending loops of Henle a 1 Penetrance is 100% at 3 months. wt # of lesions/section (penetrance) Vhlhdel/del # of lesions/section (penetrance) Hoxb7-Cre 0 (0/6) 10.2±1.2 (6/6) Hoxb7-Cre-EGFP 0 (0/11) 10.4±1.7 (11/11) Cre driver * 2 pVHL * 3 LT DBA (Proximal tubule) 4 5 NCC (Collecting duct) TH (Ascending Loop of Henle) (Distal tubule) * * * b % of distorted tubules positive for tubule markers (n=# of tubules examined) TH (n=460) DBA (n=406) 44.70% 1.97% Oncogene. 2014 Jul 14;0. [Epub ahead of print] NCC (n=399) LT (n=227) Negative (n=60) 2.51% 18.94% 18.33% Oncogene. 2014 Jul 14;0. [Epub ahead of print] Hyperplasia in Vhlhdel/del kidney tubules 100 m H&E mitotic figures A wt Aa wt Ab wt VHL-/- Bb VHL-/- # Ki67 positive cells / 10x field of view (from 4 kidneys) VHL-/- P<0.001 Ki67 B 100 m VHL-/- Ba proliferating cells Mut w.t. (n=11) (n=11) 10.00±5.081.00±1.48 Oncogene. 2014 Jul 14;0. [Epub ahead of print] 2 11/12/2014 Systemic phenotypes 1 – Liver Systemic phenotypes 2 - hematopoiesis Vhlhdel/del Liver hemangioma Clear cell lesions in the liver w.t. Unpublished Unpublished F4/80 Vhl-/- SMA w.t. # of positive cells per 20x field Infiltration of immune cells — inflammation Fibrosis in Vhl KO kidney # of positive cells per 20x field # of positive cells per 20x field B220 CD3 Sirius red Oncogene. 2014 Jul 14;0. [Epub ahead of print] Macrophages + mut 18±7.48238±78.9 50m 50 m 250 n=3 200 p=0.003* 150 100 50 100 80 60 40 20 n=3 p<0.001* B cells wt mut 0.5±159.7±11.6 250 200 150 100 50 n=3 p<0.001* T cells wt mut 12±9.38150±27.5 Oncogene. 2014 Jul 14;0. [Epub ahead of print] 3 11/12/2014 VHL patient kidney shows pre-cancerous inflammation and fibrotic lesions A Vhlhdel/del mouse VHL patient uninvolved kidney Primary Vhl mutant tubule cells show increased ERK signaling, CTGF, TGF and nuclear NFkB. 100 m B Uninvolved region CAIX Neighboring sections Sirius red ccRCC * * Oncogene. 2014 Jul 14;0. [Epub ahead of print] wt A Vhlhdel/del F A F 1 2 3 4 5 6 7 # lesions a Fold change (KO/wt)* 1 TIMP-1 9.0 tissue inhibitor of metalloproteinases 2 M-CSF 2.1 macrophage colonystimulating factor 3 CCL2/ MCP-1 8.7 4 CXCL9/ MIG 2.01 5 IL-16 1.5 monocyte chemotactic protein 1 monokine induced by gamma interferon; T cell attractant chemotactic for CD4+ cells 6 IL-1ra 8.8 IL-1 antagonist 7 CCL5/ RANTES 2.2 chemotactic for T cells, eosinophils, and basophils 20 15 10 5 0 c Collagen deposit 20 15 10 5 0 b p=0.0452* p=0.0020* % Ki67+ epithelial nuclei per 20X field 24 Identity # lesions per 4X sagittal section 1 Spot % collagen deposition 10X sagittal section b a Vhl KO phenotypes can be rescued by cytokine signaling inhibitor p=0.0440* p=0.3447 p=0.0002* p=0.0433* p=0.0001* Ki67+ cells d # macrophages # macrophages 20X sagittal section Cytokine array profile of the 3 months old Vhl KO kidney 400 p=0.0530 300 200 100 0 Rux: Ruxolitinib, a JAK1/2 inhibitor *Average of two independent samples Inflammatory response in the microenvironment is important for the initiation of tubule defects and hyperplasia. Oncogene. 2014 Jul 14;0. [Epub ahead of print] 4 11/12/2014 The Vhl mutant phenotypes are Hif1-dependent but not Hif2-dependent % Ki67+ epithelial nuclei per 20X field a p=0.3447 Tumor-host interaction — Induction of inflammatory microenvironment p=0.0002* p=0.0001* Ki67+ cells FGFR VHL mutant TGF NFkB mesenchymal characteristics # lesions 30 20 10 0 c p=0.8883 p=0.0034* p=0.0034* p=0.0440* # macrophages per 20x field # lesions per 4x sagittal section b # macrophages Cytokines/ chemokines 200 150 100 50 Recruitment Inflammation X X X X X 0 Cytokines/ chemokines X X ccRCC Immune cells Myofibroblasts Inflammation is suspected as an inducer of cancer. Oncogene. 2014 Jul 14;0. [Epub ahead of print] The anti-inflammatory property of statins is protective against kidney cancer A retrospective study of 483,733 veterans (US) has shown that statins is protective against the development of renal cell carcinoma1. Statin use was significantly associated with a risk reduction of renal cell carcinoma of 48%, irrespective of age, sex, and the presence of obesity and smoking. Also, simvastatin can inhibit renal cancer cell growth and metastasis via AKT/mTOR, ERK and IL6-induced JAK2/STAT3 pathway2. 1. Khurana V, Caldito G, Ankem M. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. Urology 2008 71:118–122. 2. Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. 2013 PLoS ONE 8:e62823. Acknowledgements Boston University: Tracy Pritchett Hannah Bader Gouthami Nallamothu Richard Near Rong Chen Collaborators: Prof. Giuseppe Gargiulo University of Bologna, Italy Dr. Boris Adryan Cambridge University National Central University: Chanyan Kuo Yu-Hui Shih Yuki Hagiwara Peter Fang Chi-chien wu 5 11/12/2014 Mouse knockout strategy Vhl knockout kidney over-produces pro-inflammatory cytokines Vhl-/- Wild-type Vhl-/- Proximal convoluted tubule Bowman's capsule Where is the origin of ccRCC? Proximal tubules or distal tubules? Distal convoluted tubule IL-1 Glomerulus Consideration for mouse knockout strategy: 1. Proximal tubules may not be the only origin of ccRCC: Use KO in distal tubules 100 m Cortex TGF1 Medulla Loop of Henle 2. Most of the knockouts were in mixed genetic background: Use a purified genetic background Collecting duct to ureter Penetrance of kidney phenotype is 100% at 3 months Basement membrane break down Periodic acid-Schiff's stain (basement membrane) wt Vhlhdel/del d p w.t. 200X Cre driver wt # of lesions/section (penetrance) Vhlhdel/del # of lesions/section (penetrance) Hoxb7-Cre 0 (0/6) 10.2±1.2 (6/6) Hoxb7-Cre-GFP 0 (0/11) 10.4±1.7 (11/11) 200X Vhl-/- 200X 6 11/12/2014 Mutant cells unassociated with the epithelia are detected in Vhl knockout kidneys Dysplastic Vhl mutant cells GFP stain Hoxb7-Cre-EGFP/VhlloxP/loxP VhlloxP/loxP VHL patient kidney shows pre-cancerous inflammation and fibrotic lesions A Vhlhdel/del mouse Mutant cells unassociated with the epitheliua are detected in Vhl knockout kidneys VHL patient uninvolved kidney Vimentin stain VhlloxP/loxP Hoxb7-Cre; VhlloxP/loxP 100 m VHL patient kidney sections B a RCC b Neighboring tissues c H&E a' Sirius red 200x 200x Infiltration of leukocytes b' c' Fibrosis Epithelial cells Interstitial cells 7 11/12/2014 Vhl KO kidney and human pre-cancer lesion show increased infilatration of myofibroblasts A v Hoxb7-Cre is expressed in collecting ducts, ascending loops of Henle and convoluted distal tubules Hoxb7-Cre-EGFP driver: PDGFR v B t GFP Tubule marker MOUSE Mouse w.t. Mouse Dolichos biflorus agglutinin (DBA) [Collecting ducts] Vhl-/- C D DBA 1 v HUMAN Human normal Merge 2 1 Human pre-cancer E TH 2 Human ccRCC NCC Tamm-Horsfall (TH) protein [Ascending loop of Henle] Thiazide sensitive NaCl Cotransporter (NCC) [Convoluted distal tubules] 8